A tripeptide with diverse biological activities
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

MSH Release-Inhibiting Factor (trifluoroacetate salt)

Item No. 24476

Technical Information
Formal Name
L-prolyl-L-leucyl-glycinamide, trifluoroacetate salt
Synonyms
  • ​Melanocyte-stimulating Hormone Release-Inhibiting Factor
  • MIF-1
  • MSH-R-IF
Molecular Formula
C13H24N4O3 • XCF3COOH
Formula Weight
Purity
≥95%
A lyophilized powder
Water: 1 mg/ml
SMILES
O=C([C@@H](NC([C@H]1NCCC1)=O)CC(C)C)NCC(N)=O.FC(F)(C(O)=O)F
InChi Code
InChI=1S/C13H24N4O3.C2HF3O2/c1-8(2)6-10(12(19)16-7-11(14)18)17-13(20)9-4-3-5-15-9;3-2(4,5)1(6)7/h8-10,15H,3-7H2,1-2H3,(H2,14,18)(H,16,19)(H,17,20);(H,6,7)/t9-,10-;/m0./s1
InChi Key
RNHWSCDHHHUWRY-IYPAPVHQSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    MSH release-inhibiting factor (MSH-R-IF) is a hypothalamic tripeptide that binds to rat striatum (Kd = 4.69 nM) and has diverse biological activities.1,2,3,4 In vivo, MSH-R-IF (0.1 mg/kg) decreases immobility of mice in the forced swim test, indicating antidepressant-like activity.2 MSH-R-IF (20 mg/kg) increases striatal concentration of dopamine (Item No. 21992) and the dopamine metabolites DOPAC, 3-methoxy tyramine (3-MT; Item No. 20511), and homovanillic acid (HVA) in a mouse model of Parkinson's disease induced by MPTP.3 It decreases vacuous chewing movements induced by haloperidol (Item No. 12014) in a rat model of tardive dyskinesia when administered at a dose of 2 mg/kg.4 MSH-R-IF also has anti-opiate effects, reversing analgesia induced by morphine (Item No. ISO60147) and an enkephalin in mice in a radiant heat tail-flick assay.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Pan, W., and Kastin, A.J. From MIF-1 to endomorphin: The Tyr-MIF-1 family of peptides. Peptides 28(12), 2411-2434 (2007).

    2. Kastin, A.J., Abel, D.A., Ehrensing, R.H., et alTyr-MIF-1 and MIF-1 are active in the water wheel test for antidepressant drugs. Pharmacol. Biochem. Behav. 21(5), 767-771 (1984).

    3. Marcotte, E.R., Chugh, A., Mishra, R.K., et alProtection against MPTP treatment by an analog of Pro-Leu-Gly-NH2 (PLG, MIF-1). Peptides 19(2), 403-406 (1998).

    4. Sharma, S., Paladino, P., Gabriele, J., et alPro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: A model of human tardive dyskinesia. Peptides 24(2), 313-319 (2003).